NY bust: Medicaid patients' Rx drugs go to dealers

Dec 05, 2010 By CAROLYN THOMPSON , Associated Press

(AP) -- Police in western New York have charged 33 people so far in an investigation that shows a new kind of supplier in the illicit drug trade.

They say medical patients, including many who rely on Medicaid for prescriptions, have become a popular way to get drugs like to the street.

The patients see a doctor, or several doctors, and come away with prescriptions they sell to a dealer for as much as $1,000. Drug Enforcement Administration agents say the dealer can get $7,200 for the in that one bottle.

A federal report last year estimated 65,000 Medicaid beneficiaries in New York and four other states visited doctors in 2006 and 2007 to get prescriptions for the same type of controlled substances. The cost to was $63 million.

Explore further: FDA approves hard-to-abuse narcotic painkiller

4.7 /5 (3 votes)
add to favorites email to friend print save as pdf

Related Stories

Medicaid policies vary widely for rheumatoid arthritis drugs

Nov 04, 2008

Patients with inflammatory diseases such as rheumatoid arthritis now have many more treatment options than in the past, including biologic disease-modifying antirheumatic drugs (DMARDs). These drugs, derived by modifying ...

11 people charged in Detroit painkiller scam

Jun 04, 2009

(AP) -- A federal indictment in Detroit says the government unwittingly paid more than $480,000 to a phony health-care business that was a front for acquiring and selling powerful painkillers as far away as Alabama.

Physicians click their way to better prescriptions

Mar 10, 2010

Is it time for all community-based doctors to turn to e-prescribing to cut down on the number of medication errors? According to Rainu Kaushal and colleagues from the Weill Cornell Medical College in New York, electronic ...

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments : 0